Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00757744 · ClinicalTrials.gov registry record · Phase 3
Behavioral Drug and HIV Risk Reduction Counseling in Methadone Patients in China
A Phase 3 study, sponsored by Yale University.
- Completed
- Registry status
- Phase 3
- Development phase
- 45
- Enrollment target
NCT00757744 is a Phase 3 study that has completed, run by Yale University. The registered enrollment target is 45 participants.
The verdict
NCT00757744, a Phase 3 study, has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 45 participants
- Enrollment target
Study Summary
A randomized clinical trial evaluating the reduction of HIV risk behaviors and drug use when providing integrated behavioral drug and HIV risk reduction counseling (BDRC) along with methadone maintenance treatment in Wuhan, China
Interventions
- BEHAVIORAL Behavioral Drug and HIV Risk Reduction Counseling (BDRC)
- BEHAVIORAL Drug counseling
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2007-09 |
| Est. Completion | 2010-09 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00757744
The ClinicalTrials.gov registry entry for NCT00757744 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 45 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Behavioral Drug and HIV Risk Reduction Counseling (BDRC) is the first listed.
NCT00757744 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00757744 about?
NCT00757744 is a clinical study titled "Behavioral Drug and HIV Risk Reduction Counseling in Methadone Patients in China". A randomized clinical trial evaluating the reduction of HIV risk behaviors and drug use when providing integrated behavioral drug and HIV risk reduction counseling (BDRC) along with methadone maintenance treatment in Wuhan, China
What is the current status of trial NCT00757744?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 45 participants. The study started on 2007-09. Estimated completion is 2010-09.
What interventions are being tested in trial NCT00757744?
The interventions under investigation include: Behavioral Drug and HIV Risk Reduction Counseling (BDRC) (BEHAVIORAL), Drug counseling (BEHAVIORAL).
Who is sponsoring clinical trial NCT00757744?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.